ArticleJNCI cancer spectrum2025
Trends in stage-specific prostate cancer incidence by neighborhood socioeconomic status.
Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Years of life lost from metastatic prostate cancer according to household income.World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Changes in screening guidelines have influenced stage at diagnosis for prostate cancer, but it remains unclear whether these trends differ by neighborhood socioeconomic status (SES). Using cancer registry data from the Surveillance, Epidemiology, and End Results program from 2011 to 2020, we estimated age-standardized stage-specific incidence rates and annual percent changes for localized and distant prostate cancer incidence by neighborhood SES quintile and age group. Incidence of localized prostate cancer was highest in higher neighborhood SES areas, while distant prostate cancer rates were highest in areas with lowest neighborhood SES. Annual percent changes in localized prostate cancer incidence were similar by neighborhood SES over the decade, whereas the differences in distant prostate cancer incidence by neighborhood SES diminished over this period. The differing trends in localized and distant prostate cancer incidence by neighborhood SES highlight the importance of equitable access to screening among younger high-risk individuals and improved personalized screening strategies among older men based on health status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.